# Tight Glycemic Control With Intensive Insulin Therapy in PICU

> **NCT00214916** · PHASE2 · UNKNOWN · sponsor: **Greet Van den Berghe** · enrollment: 700 (actual)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** intensive insulin therapy (Actrapid IV to normoglycemia)
- **DRUG:** conventional insulin therapy (Actrapid IV only for excessive hyperglycemia)

## Key facts

- **NCT ID:** NCT00214916
- **Lead sponsor:** Greet Van den Berghe
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-10
- **Primary completion:** 2008-02
- **Final completion:** 2023-06
- **Target enrollment:** 700 (ACTUAL)
- **Last updated:** 2022-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214916, "Tight Glycemic Control With Intensive Insulin Therapy in PICU". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00214916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*